CLYM: Climb Bio, Inc. Stock

by  •  • Comments Off on CLYM: Climb Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 80.97
Enterprise Value ($M) -6.26
Book Value ($M) 211.88
Book Value / Share 3.14
Price / Book 0.38
NCAV ($M) 149.57
NCAV / Share 2.22
Price / NCAV 0.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.68
Return on Equity (ROE) -0.69

Liquidity (mrq)
Quick Ratio 31.41
Current Ratio 31.41

Balance Sheet (mrq) ($M)
Current Assets 154.87
Assets 217.19
Liabilities 5.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -27.00
Net Income -73.90

Cash Flow Statement (mra) ($M)
Cash From Operations -15.56
Cash from Investing -121.09
Cash from Financing 130.73

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A BML Investment Partners, L.P. 0.00 -100.00
11-14 13G/A Deep Track Capital, LP 3.23 -44.45
11-13 13D/A Access Industries Management, Llc 7.25
08-16 13D/A Ai Eti Llc 7.50 0.00
08-14 13G/A Affinity Asset Advisors, LLC 2.70 8.57
07-01 13D/A Ra Capital Management, L.p. 47.10 138.49

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 30,537 103,899 29.39
2025-04-01 59,015 252,681 23.36
2025-03-31 12,009 57,024 21.06
2025-03-28 15,198 91,138 16.68

(click for more detail)

Similar Companies
CARM – Carisma Therapeutics, Inc. CHRS – Coherus BioSciences, Inc.
CLSD – Clearside Biomedical, Inc. CMRX – Chimerix, Inc.
CRMD – CorMedix Inc.


Financial data and stock pages provided by
Fintel.io